Chinese drug discovery firm BioMap bags $100m Series A led by GGV Capital

Chinese drug discovery firm BioMap bags $100m Series A led by GGV Capital

30 July, 2021

BioMap GGV Capital

Printed by Unregistered user on Tue, 22 Jul 2025 03:53:41 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China's Geneplus Technology nets $116m Series C funding led by CCB International

China's Baidu posts 25% rise in quarterly revenue

Read more from Greater China

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation